Business Context and Reporting Period
This Form 8-K Current Report was filed by The Mosaic Company on May 29, 2014. The filing addresses Item 5.02 regarding the departure of certain officers and the appointment of interim leadership due to a medical leave of absence.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation adjustments and personnel changes.
Material Changes
- CEO Medical Leave: James T. Prokopanko, President and CEO, is taking an anticipated medical leave of absence for cancer surgery effective June 1, 2014.
- Interim CEO Appointment: Lawrence W. Stranghoener (formerly Executive Vice President and CFO) was named Interim CEO effective June 1, 2014.
- CFO Appointment: Richard L. Mack (formerly Executive Vice President, General Counsel, and Corporate Secretary) was appointed Executive Vice President and CFO effective June 1, 2014.
- Compensation Adjustments:
- Mr. Stranghoener's annual base salary increased from $675,000 to $1,125,000.
- Mr. Stranghoener's target bonus increased from 85% to 125% of his annual base salary.
- Mr. Mack's annual base salary increased from $550,000 to $600,000.
- Mr. Mack's target bonus remains at 80% of his annual base salary.
Outlook, Risks, and Management Commentary
Upon Mr. Prokopanko's return from medical leave, Mr. Stranghoener will transition to Executive Vice President – Strategy and Business Development until his planned retirement on December 31, 2014. The filing notes the medical nature of the CEO's absence but does not provide specific timelines for recovery or operational risks beyond the leadership transition.
Investor Verification Checklist
- Verify the duration of James T. Prokopanko's medical leave and expected return date.
- Confirm the operational impact of the interim leadership structure on strategic initiatives.
- Review the specific terms of the Management Incentive Plan adjustments for 2014.
- Monitor future filings for updates on Mr. Prokopanko's health status and Mr. Stranghoener's retirement timeline.